Philippines Eases Prescription Rules for Critical Drugs

Temporary measure addresses public health threats.

To improve access to essential treatments, the Dangerous Drugs Board (DDB) has approved the temporary use of regular prescriptions for specific controlled medications. The decision comes amid concerns over mpox, rising COVID-19 infections, and a surge in HIV cases.

New Prescription Guidelines

Under Board Regulation No. 10, Series of 2025, practitioners with an S2 license can issue triplicate copies of standard prescriptions for medicines containing dangerous drugs. This eliminates the need for special yellow prescription forms typically required by the Department of Health.

“This temporary regulatory flexibility is part of the government’s broader response to ensure uninterrupted care for patients affected by these public health threats,” said DDB Chairperson Secretary Oscar Valenzuela.

As Valenzuela noted, “By easing prescription requirements for essential medications, we empower healthcare providers to deliver timely and essential treatments, especially in underserved communities.”

Rationale Behind the Decision

The measure aligns with World Health Organization (WHO) recommendations for improved access to regulated therapeutics. It also responds to a dramatic rise in HIV infections among young Filipinos.

HIV cases among young Filipinos up by 500% – DOH https://t.co/xWuQTtJ9jz

— GMA News (@gmanews) March 28, 2024

Notably, a recent study published in *The Lancet* found that disruptions to HIV treatment access can lead to a 30% increase in new infections.

Safeguards and Enforcement

The new regulation includes guidelines for prescription content and handling, such as prescription duration, conditions for multi-month prescriptions, pharmacist responsibilities, and physician record management. These safeguards aim to balance accessibility with accountability.

Criminal and administrative sanctions under Republic Act No. 9165, the Comprehensive Dangerous Drugs Act of 2002, remain in effect. These measures ensure the temporary use of ordinary prescriptions is not abused.

“We are reinforcing our commitment to public health while ensuring the proper oversight of controlled substances. This is a science-based, patient-centered policy that aligns with our duty to protect life while upholding the integrity of our drug control measures,” said Valenzuela.

Implementation and Sunset Clause

The regulation takes effect 15 days after publication and official registration. Unless repealed, it will remain valid until June 30, 2026.